Sabar Karimah Es bought CAPR
April 1, 2026 · Form 4 insider transaction
Sabar Karimah Es bought 53,735 shares of Capricor Therapeutics, Inc. at $4.86 per share, a transaction worth $261.2K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
53,735
Price
$4.86
Total value
$261.2K
InsiderSabar Karimah Es
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 1, 2026
Filing dateApril 1, 2026
Shares owned after53,735
OwnershipDirect
10b5-1 planNo
AmendedNo